HIGHLIGHTS
- who: C-raclopride . Receptor occupancy and collaborators from the Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands have published the article: Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses, in the Journal: (JOURNAL)
- what: This study examined sigma-1R and D2R by the stabilizer (ACR16) at behaviorally relevant doses in living rats.
- how: The biodistribution VT and BP data were analyzed using ANOVA.
- future: Future experiments employing sigma-1R knockout animals rather than a pharmacological blocking . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.